You are here

Final decisions amending, or not amending, the current Poisons Standard, April 2018

Scheduling medicines and poisons

10 April 2018

Book pagination

1.4 Ibutamoren

Part A - Final decisions on matters referred to an expert advisory committee (November 2017)

1. Advisory Committee on Medicines Scheduling (ACMS #22)

1.4 Ibutamoren

Delegate's final decision
Final decision:

The delegate's final decision is to include ibutamoren in Schedule 4 with an Appendix D (Part 5) entry as follows:

Schedule 4 - New Entry


Appendix D, Part 5 - New Entry


Index - New Entry

cross reference: MK-677, Nutrobal

Schedule 4
Appendix D, Part 5

Implementation date: 1 June 2018

As no new evidence has been received to alter the interim decision for ibutamoren, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.

Public submissions on the interim decision

No public submissions were received.

Interim decision

The interim decision for ibutamoren was published on the TGA website on 5 February 2018 at Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017 - 1.4. Ibutamoren.

Scheduling proposal

The pre-meeting scheduling proposal for ibutamoren was published on the TGA website on 6 September 2017 at Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017.

Book pagination